Inception Return
(12/14/2012)
|
11.35 %
|
|
YTD Return
|
19.05 %
|
|
NAVPS
(12/11/2024)
|
$26.16
|
|
Change
|
$0.14 / 0.52 %
|
|
|
Growth of $10,000
(As of November 30, 2024)
|
|
MER
|
2.03 %
|
|
Assets ($mil)
|
$2,132.74
|
|
Rank (1Yr)
|
466/578
|
|
Std Dev (3Yr)
|
15.99 %
|
|
Volatility Ranking (3Yr)
|
7/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Back Fee Only
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The fundamental objective of the Pool is to seek to provide a combination of income and long-term capital appreciation. The Pool will invest in a diversified portfolio, of which the equity portion will be comprised of mainly Canadian dividend paying common and preferred equity securities. The Pool may also invest in real estate investment trusts (“REITs”) and royalty trusts. A portion of the Pool’s assets may also be held in foreign securities.
|
Fund Manager
Manulife Investment Management Limited
Portfolio Manager
Alan Wicks, Manulife Investment Management Limited
Jonathan Popper, Manulife Investment Management Limited
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of October 31, 2024)
|
Sector Allocation
(As of October 31, 2024)
|
Geographic Allocation
(As of October 31, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Fidelity National Info Srvcs Inc | US Equity | Financial Services | United States | 4.02% |
| Constellation Software Inc | Canadian Equity | Technology | Canada | 3.96% |
| Waste Connections Inc | Canadian Equity | Industrial Services | Canada | 3.81% |
| Royal Bank of Canada | Canadian Equity | Financial Services | Canada | 3.48% |
| W R Berkley Corp | US Equity | Financial Services | United States | 3.42% |
| Intact Financial Corp | Canadian Equity | Financial Services | Canada | 3.41% |
| Alphabet Inc Cl A | US Equity | Technology | United States | 3.40% |
| Canadian Natural Resources Ltd | Canadian Equity | Energy | Canada | 3.28% |
| Linde PLC | International Equity | Basic Materials | European Union | 3.13% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 2.96% |
Performance Data
(As of November 30, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
4.83
|
6.80
|
11.72
|
19.05
|
21.32
|
3.26
|
9.69
|
9.23
|
|
Benchmark
|
5.65
|
9.52
|
15.38
|
25.41
|
29.65
|
10.17
|
11.41
|
9.16
|
|
Quartile Ranking
|
3
|
4
|
4
|
3
|
4
|
4
|
3
|
2
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
10.02
|
-17.09
|
20.65
|
21.26
|
22.87
|
-4.22
|
12.95
|
15.61
|
-0.84
|
19.04
|
|
Benchmark
|
13.60
|
-8.87
|
21.76
|
7.58
|
21.45
|
-7.14
|
10.80
|
14.44
|
-0.77
|
10.96
|
|
Quartile Ranking
|
4
|
4
|
4
|
1
|
1
|
1
|
2
|
2
|
3
|
1
|